Introduction:
Hepatitis C is a virally infectious disease, which affects 3% of the world and 4.8 % of the Pakistani population [1] [2] [3] , highlighting the demand for rapid, routine, reliable and cost effective diagnostic techniques. Presently, screening methods depend upon the detection of antibodies and pathogens in Hepatitis C virus (HCV) infected blood [4] . The serology based method, Enzyme Linked Immunosorbent Assay (ELISA), targets specific antibodies arising in the blood from the response of the immune system due to HCV infection [5] . However, although ELISA is very commonly employed, it is not a very reliable method for diagnosis of HCV infection. False positive and false negative anti-HCV results pose severe difficulties in medical practice and in blood screening [6] [7] [8] .
More direct virus detection based methods employ Polymerase Chain Reaction (PCR), in which HCV RNA, considered the most reliable disease marker, is detectable in serum or plasma as early as one week after infection and the technique is considered the gold standard for diagnosis of active HCV infection [9] [10] . The accuracy of the molecular based detection method depends upon the quality of the chemical reagents used and the sensitivity of the instrumentation. It involves very complex processes, and therefore an expert operator is required to carry out the test, which can otherwise lead to significant errors. More recently, "real-time" PCR techniques have been developed [11] [12] [13] [14] [15] . A comparison of ELISA and PCR methods has been carried out [16] [17] , leading to the conclusion that PCR based techniques are the most reliable, although they are very expensive, time consuming, laborious and less commonly available. There is a need, therefore, to develop a new, reliable, efficient, rapid, automated, cost effective, non-invasive and biochemical label free diagnosis method to screen the whole community for effective disease management.
Over the last decade, Raman spectroscopy has shown great potential for the characterization of biological tissue [18] and the effect of external agents on the cell [19] [20] [21] [22] [23] [24] . In addition, Raman spectroscopy can provide high content information, as it can examine spectral changes in any bio-macromolecules including DNA, proteins, lipids simultaneously [25] [26] [27] and can lead towards the identification of the Raman spectral features which could be utilized as diagnostic markers of the disease. Moreover, Raman micro-spectroscopy has been employed to explore sub-cellular biochemical structure, as demonstrated by its use in studies investigating the action of various agents on biological macromolecules as well as their interaction with cancer cells [20, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] .
Recently, Raman spectroscopy has been successfully employed for the diagnosis and characterization of viral infections such as dengue [38] , HPV [39] [40] and others [41] [42] .
Although the diagnosis of HCV in the sera samples from virally infected patients by employing Raman spectroscopy has been reported [43] , there is no work published to date in which the technique has been applied to study the correlation of the biochemical signatures of the virus with the viral loads. In the current work, Raman spectroscopy is employed to identify the biochemical changes associated with the HCV virus infection by studying infected human plasma samples, along with healthy samples as control, in order to establish the Raman spectral markers associated with the HCV infection. Furthermore, the multivariate techniques of Principal Components Analysis (PCA), coupled with Linear Discriminants Analysis (LDA), and Partial Least Squares Regression (PLSR) were employed for Raman spectral analysis. PCA was used to discriminate the Raman spectra from the diseased blood sera from the healthy ones, and coupled with LDA, to improve the diagnostic potential, whereas, PLSR models are developed based on the Raman spectra of diseased and healthy samples to predict the viral loads of the HCV infected plasma on the basis of the biochemical changes caused by the viral infection.
Materials and Methods

Sample preparation
Blood plasma samples from 10 healthy (control) and 10 confirmed Hepatitis C patients with different viral load (VL) values, given in the Table 1 , were collected from PINUM Hospital, Faisalabad, Pakistan and approved for study by the ethical committee. These patients were diagnosed as infected with HCV by the Polymerase Chain Reaction (PCR) technique, currently a gold standard for the diagnosis of Hepatitis, which quantified the HCV loads in the patient samples ( Table 1) . A drop of each plasma sample (20 µl -around 5 mm in diameter) was placed on an Aluminium slide at room temperature. The Raman spectra were acquired from samples ensuring that the blood plasma samples did not dry during the measurement time. Blood plasma samples were handled according to the US National Institute of Health (NIH) recommendations.
Raman spectral acquisition
Raman spectral acquisition from all of the 10 control and 10 HCV positive plasma samples was performed using a Raman spectrometer (Peak Seeker Pro-785; Agiltron, USA). The Peak Seeker Pro-785 utilizes a 785 nm diode laser as the excitation source, delivering a laser power of ~70 mW at the sample. The laser was delivered to the sample through a 10X. The CCD used for recording the Raman scattering was cooled by a thermoelectric cooler to minimize the electrical noise. The acquisition of the Raman spectra for all the samples was executed from 400 to 1800 cm -1 and 30-35 Raman spectra per sample were acquired with an acquisition time of 30 seconds each.
Data pre-processing
All data processing of the Raman spectra was performed using MatLab 7.2 and established protocols [44] . Data pre-processing included smoothing, baseline correction, vector normalization and substrate removal. All spectra, including substrate backgrounds, were vector normalized and smoothed using a Savitzky-Golay smoothing method (order 5, 13 point window). A rubber band correction for baseline removal for all the spectra was carried out and the substrate spectra were subtracted from each spectrum.
Data analysis
The Raman spectral data have been analysed by comparing the mean spectra of each patient, including control/healthy persons as well as HCV patients. The assignments of the Raman spectral features used in interpretation of the results were taken from the literature [24, 35, [45] [46] and are described in Table 2 .
In order to further elucidate the biochemical basis of the development of HCV as compared to the healthy/control samples, PCA was performed. PCA is a mathematical procedure involving the transformation of possibly correlated variables into a smaller number of uncorrelated variables, known as principal components (PC), basically to reduce the dimensionality of the data whilst maintaining their variability. The first principal component accounts for the dominant source of variability in the data, and each succeeding principal component accounts for the next highest source of the remaining variability. The loadings of the PC can be understood as the orthogonal dimensions of biochemical differences which facilitate separation of different groups of spectra of Raman data along their variability as each spectrum scores along these dimensions.
To improve the diagnostic potential, PCA-LDA was then performed on the whole dataset to produce confusion matrices using the scores [47] . Specifically, the algorithm was performed using a stratified 10-fold cross validation, splitting the data into calibrations and test sets. For each virus load tested, 90% of the Raman spectra were used for calibration while the remaining 10% constituted the test sets. Ultimately, the confusion matrix built results from the 10 iterations and gives the overall classification from the 10 test sets. The classification which resulted in the maximum accuracy while keeping the number of latent variables to a minimum was chosen for all successive models. In the case of all HCV versus Control samples, the maximum accuracy was found when 3 principal components were used in the classification. Further addition of principal components only increased the complexity of the model without further improving the performance.
PLSR is a common chemometric method which aims to construct a generic model to describe the response variables (i.e. analyte concentration) in terms of the observed variables (spectra) from a set of training data (viral load). The least squares model is given by an equation system whose dependent result is given by the measured variables (i.e. viral load in this case). The independent variables (the spectra) are regressed towards those dependent variables with the regression parameter, leaving residuals (differences between measured and predicted variables) which are suitable to access the quality of the predictive model and the parameters for model optimisation.
PLSR is similar to PCA, which produces factors based on variance solely within the data matrix, whereas PLSR considers both target and the data matrix, ensuring that the factors correlate the data matrix (spectra) to the target variable (viral load). In PLSR, the variables are regressed simultaneously, maximizing the covariance between both matrices to allowing direct correlation between the spectra and target. PLSR models in this work were constructed using the SIMPLS algorithm with root mean squared error of cross validation (RMSE) as the fitness value. Leaveone-out cross validation was used to select the minimum number of latent variables (LV's comparable to PC's) to retain in order to create a robust and sufficiently ubiquitous model but still avoid over fitting. Notably, among the Raman spectral features labelled with the solid lines, there are a few peaks, including those at 874, 880, 1054, 1065, 1072 and 1211 cm -1 , which are encircled to show their significance as these are not observed in the mean control spectra but are very significant in the HCV ones. Of these, the features at 874 and 880 cm -1 (tryptophan ring breathing), 1054 cm -1 (C-N stretching) and 1211 cm -1 (amide-III beta sheet or phenyl stretching in amino acids) are associated with proteins and mat be associated with Raman spectral markers of the proteinic part of the HPV itself, or its physiological impact.
Results and Discussion
Raman spectral changes associated with proteins were observed. Among those peaks, it is important to mention that the peak ratio of the 748 cm -1 (CH 2 bending) and 758 cm -1 (Tryptophan ring breathing) features is changed in the HCV positive sample as compared to the Normal and the peak height of the peak at 748 cm -1 is increased in the HCV positive sample as compared to control. Moreover, a shoulder is observed at 606 cm -1 (CH 2 bending), near 620 cm -1 (C-C twisting). In addition, the peak ratio of the 1090 and 1099 cm -1 (C-N stretching) peaks is also changed and a decrease in the peak height is observed in the HCV positive sample as compared to the Normal. These changes may be attributed to some kind of structural changes in the proteins which might be involved in the development of the HCV infection, and hence can be taken as Raman spectral markers of the HCV infection.
Other Raman spectral features observed, related to the proteins, consist of those at 422, 426 and 860 cm -1 (C-C stretching), 620 cm -1 (C-C twisting), 720, 758, 1360 and 1378 cm -1 (Tryptophan ring breathing), 838 cm -1 (Tyrosine ring breathing), 880, 898, 1150, 1197 cm -1 (C-C skeletal stretching), 934 cm -1 (C-C alpha helix of protein), 1090, 1099, 1157, and 1164 cm -1 (C-N stretching), 1222, 1228, 1242 and 1254 cm -1 (Amide-III beta sheet) and 1655 cm -1 (amide-I).
These changes related to protein can be associated with the development of the disease.
Moreover, the peaks at 1065 and 1072 cm -1 , both associated with the fatty acids (lipids), may also be associated with the viral infection. Other lipid related changes observed include the features at 711 cm -1 (C-N stretching), 984 cm -1 (C-C head groups) and 1393 cm -1 (CH 3 deformation). The observed changes may be the result of an increase in the levels of the lipids as well as conformational changes in some lipidic structures, indicating their involvement in the process of the viral infection. It is reported that lipid droplets provide sites for the attachment of the HCV, necessary for replication in the infected host [48] .
In the case of the study of cervical cancer tissue samples, in which the Human Papilloma virus (HPV) is considered a primary aetiological factor, it was observed with Raman spectroscopy that proteinic indicators of the presence of the virus are readily identifiable, although the DNA/RNA signatures of the virus itself are not so prominent [37, 40, 49] . It can hence be concluded that the effects of the virus are more evident than the virus itself.
Principal Component analysis (PCA)
In order to further explore the ability of the PCA to differentiate between one normal and HCV positive sample, PCA was applied to their Raman spectral data. Figure 3 and Figure 4 show the scatter plot and loadings of the PCA of Normal (one group) versus HCV plasma (one patient) of highest viral load (V.L. = 1,718,359 IU/ml, positive-17 of Table-1 ). There is clear differentiation of the two groups of Raman spectra observed by PC-1, explaining 87.7% of the variance in the data. The loadings of PC1, Figure 4 , confirm the results discussed earlier in the case of the difference of the mean spectra, although they are inverted (Figure 2) . Notably, the Raman spectra of the "normal plasma samples" are clustered in the negative side and HCV positive ones in the positive side of the PC1 axis of the PCA scatter plot and hence the spectral features associated with the HCV plasma are loaded positively, while those of the Normal plasma are loaded negatively [50] . The features identified in Figure 2 , also feature in the Loading of PC1, and are labelled with solid lines which are encircled to show their significance. Of these, those at 874 cm -1 and 880 cm -1 (tryptophan ring breathing) and 1054 cm -1 (C-N stretching) and 1211 cm -cm -1 (Tyrosine ring breathing), 880 cm -1 (C-C skeletal stretching), 1150 cm -1 (C-C skeletal stretching), 1360 and 1378 cm -1 (Tryptophan ring breathing) and 1393 cm -1 (CH 3 deformation).
Moreover, a shoulder is observed at 606 cm -1 (CH 2 bending), near 620 cm -1 (C-C twisting) as a loading in the positive again associated with HCV sample. In addition, the peak ratio of the 1090 and 1099 cm -1 (C-N stretching) peaks is also changed and a decrease in the peak height is observed in the HCV positive sample as compared to the control indicated by their observation as negative loadings. These changes may be attributed to some kind of structural changes in the proteins which might be involved in the development of the HCV infection, and hence can be taken as Raman spectral markers of the HCV infection.
Other Raman spectral features observed as negative loadings (associated with normal sample), related to the proteins, including those at and 860 cm -1 (C-C stretching), 620 cm -1 (C-C twisting), 898 cm -1 (C-C skeletal stretching), 934 cm -1 (C-C alpha helix of protein), 1090, 1099, (C-N stretching), may also be associated with structural changes in proteins. Notably, the Raman spectral feature at 1655 cm -1 (amide-I) is observed at 1659 cm -1 in Figure 4 (loading plot of PCA) which indicates a shift in this band and can be associated with the changes in the secondary structure of the proteins which may be involved in the development of the disease.
PCA-LDA
Having demonstrated the capability of Raman spectroscopy to identify spectral differences consistent with and indicative of the presence of HVC in blood plasma samples, the diagnostic potential to identify the presence of viral infection in patient samples over the range of viral loadings can be assessed using PCA-LDA. This approach becomes quite relevant when facing large data sets scattered over multidimensional plots such as PCA scatter plot. While the graphical representation can be useful to visualise patterns in the data distribution, the specificity of the classification is not quantifiable. PCA-LDA allows taking into account the whole data set (783 spectra from 10 patients of varying viral load) and computing a confusion matrix according to a 10-fold stratified cross validation model. As a result, the accuracy of the classification between control and HVC samples can be estimated based on the variations in the spectral features highlighted by the PCA analysis. Table 3 shows the confusion matrix built using the 3 first PC, which was found to be the optimal. It can be seen that, out of 293 spectra collected from control samples, only 4 are misclassified as HCV infected, while 6 of the 490 HCV spectra are misclassified as control. The overall sensitivity and specificity of the model are thus, respectively, 98.8% and 98.6%, resulting in a Positive Predictive Value of 99.2%, and Negative Predictive Value of 98% [51] .
Partial Least Square Regression (PLSR) model for prediction of viral load
Raman micro spectroscopy can clearly fingerprint the biochemical changes associated with the development of Hepatitis C due to viral infection. PCA has been used to identify specific spectral changes which are correlated with the viral load values in the plasma of the HCV patients. PCA-LDA can be employed to improve the diagnostic capability of the technique. Here, it is demonstrated that PLSR modelling can be employed for the prediction of the viral load values based on the Raman spectroscopic response. Once established, such predictive models could be used to evaluate and monitor the viral loads of the patients before and after treatment of the disease.
PLSR models of Raman spectra acquired from the plasma of the control and HCV patients versus HCV loads were constructed to determine the ability of the spectral data to predict the level of viral infection. Spectra of all normal and HCV infected patients were compiled into a matrix, and were randomly selected for modelling. A total of 60% of the spectra were used to train the PLSR regression model and 40% of the total was retained as an independent test set to assess the performance of the model in predicting the viral loads, with unseen data. Leave-one out cross validation with the calibration set was used to determine the optimal model complexity for use in testing [52] . This process was performed with randomization of the data matrix and splitting of the data to prevent data bias [53] . Control of over fitting was achieved using a procedure previously described by Martens and Naes [54] . The procedure involves selection of the optimal number of latent variables (LV) to retain within the PLSR model via cross-validation (in this case 10 fold) with the calibration data set. The optimal number of LV's was then selected on the basis of the number which provided the lowest root mean squared error after cross validation. Figure 5 represents the PLSR model development and the optimal number of LVs, which appears to be 20 (Figure 5-A) , which is the most applicable prediction of the HCV viral loads (with an accuracy of 99.8 % as shown in Figure 5-B) . In other words, the Root Mean Square Error of Prediction (RMSEP) is 0.2 %. Notably, the models were built with up to 20 latent variables which gave the minimum prediction error (predicted viral loads), as shown in Figure 6 (every circle represents the prediction response vs. fit response of a training spectrum). However, the actual viral load of a sample can be predicted sufficiently, according to its spectral response, with an accuracy of 99.8 % with a model that has 20 latent variables. The R 2 value was determined to be 0.96. Low numbers of latent variables improve the likelihood that the model will be transferrable to unseen data and minimise the possibility of over fitting [54] .
Conclusion
Although the analysis of the available data can only be understood as a preliminary proof of concept study, Raman spectroscopy in conjunction with multivariate data analysis has been shown to be a potentially powerful technique for the identification of the biochemical changes 
